文献速递肝胆胰外科围术期管理与 ERAS

胰十二指肠切除术后胰腺功能不全的长期结局与危险因素

Long-term outcomes and risk factors of pancreatic insufficiency after a pancreatoduodenectomy: A retrospective study.
PubMed 文献 · Surgery · 2024-06-15

结果显示14%发生内分泌功能不全、24%发生外分泌功能不全;术后1年残留胰管支架、淋巴结转移和胰腺萎缩是外分泌功能不全的独立危险因素,术前糖化血红蛋白、残留支架和术后主胰管扩张是内分泌功能不全的危险因素。

要点

  • 术后1年残留胰管支架是内外分泌功能不全的共同危险因素
  • 术后胰腺萎缩独立预测外分泌功能不全,主胰管扩张预测内分泌功能不全
  • 胰腺导管腺癌患者外分泌功能不全与术前胰腺功能下降相关

核心结论

  • 术后胰腺萎缩和主胰管扩张分别是外分泌和内分泌功能不全的危险因素,残留胰管支架影响两种功能障碍。

主要发现

  • 206例中14%发生内分泌功能不全,24%发生外分泌功能不全。
  • 外分泌功能不全的独立危险因素为术后1年残留胰管支架、淋巴结转移和术后胰腺萎缩。
  • 内分泌功能不全的危险因素为术前糖化血红蛋白水平、残留胰管支架和术后主胰管扩张。
  • 胰腺导管腺癌亚组中外分泌功能不全与术前胰腺功能下降(高糖化血红蛋白和低术后胰瘘率)相关。
  • 非胰腺导管腺癌患者外分泌功能不全受高发术后胰瘘影响。

关键数值与推荐

  • 外分泌功能不全定义为需补充胰酶的脂肪泻和新发脂肪变性。
  • 内分泌功能不全定义为术后新发糖尿病。

临床怎么用

  • 术后应关注残留胰管支架管理,可能有助于预防远期胰腺功能不全。
  • 对术后胰腺萎缩和主胰管扩张患者应警惕相应胰腺功能不全。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: An increasing number of patients are achieving long-term survival after pancreatoduodenectomy, meaning that risk assessments of endocrine and exocrine pancreatic insufficiency are needed. Herein, we investigated the risk factors for pancreatic insufficiency after pancreatoduodenectomy by incorporating pancreatic morphologic changes and perioperative factors. METHODS: Patients who underwent pancreatoduodenectomy between January 2015 and December 2020 were enrolled in this single-center retrospective study. Clinicopathologic, surgical, and pancreatic morphologic factors were collected, and risk factors for exocrine pancreatic insufficiency and endocrine pancreatic insufficiency were analyzed. Exocrine pancreatic insufficiency was defined as steatorrhea requiring pancreatic enzymes and new onset steatosis, and endocrine pancreatic insufficiency was defined as postoperative new-onset diabetes mellitus. Multivariate analysis was performed. RESULTS: Among the 206 patients enrolled, 14% and 24% developed endocrine pancreatic insufficiency and exocrine pancreatic insufficiency, respectively. Multivariate analysis revealed residual pancreatic stent 1 year postoperatively, lymph node metastasis, and postoperative pancreatic atrophy (P-atrophy) as independent risk factors for exocrine pancreatic insufficiency, whereas preoperative glycated hemoglobin levels, residual pancreatic stent, and postoperative main pancreatic duct dilatation were risk factors for endocrine pancreatic insufficiency. Subgroup analysis of pancreatic ductal adenocarcinoma revealed that exocrine pancreatic insufficiency in patients with pancreatic ductal adenocarcinoma was caused by preoperative decreased pancreatic function (high glycated hemoglobin and a low postoperative pancreatic fistula rate), whereas the high incidence of POPF influenced the development of exocrine pancreatic insufficiency in patients without pancreatic ductal adenocarcinoma. CONCLUSION: Postoperative pancreatic atrophy and main pancreatic duct dilatation are risk factors for exocrine pancreatic insufficiency I and endocrine pancreatic insufficiency, respectively, and residual pancreatic stent affects both types of pancreatic dysfunction. Improving the surgical approach and stent management may help prevent these late complications.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Kato T, Watanabe Y, Oshima Y, et al. Long-term outcomes and risk factors of pancreatic insufficiency after a pancreatoduodenectomy: A retrospective study. Surgery. 2024. PMID: 38879380. doi:10.1016/j.surg.2024.04.041

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。